Synthesis of mesoporous silica nanoparticle-encapsulated alginate microparticles for sustained release and targeting therapy

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 102, Issue 2, 2014, Pages 293-302

  Liao, Yu Te ^a   Wu, Kevin C W ^a   Yu, Jiashing ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

alginate; cell specific targeting; mesoporous silica nanoparticle; sustained release

Indexed keywords

ALGINATE MICROPARTICLES; ALGINATE SOLUTIONS; CELL-SPECIFIC TARGETING; DRUG DELIVERY SYSTEM; INTRACELLULAR DRUG DELIVERY; MESOPOROUS SILICA NANOPARTICLES; PHOSPHATE-BUFFERED SALINES; SUSTAINED RELEASE;

AMINO ACIDS; CALCIUM; DRUG DELIVERY; FLOW RATE;

ALGINATE;

ALGINIC ACID; ARGININE; ASPARTIC ACID; DOXORUBICIN; GLYCINE; MESOPOROUS SILICA NANOPARTICLE ENCAPSULATED ALGINATE MICROPARTICLE; RHODAMINE 6G; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; SYNTHESIS;

ALGINATE; CELL-SPECIFIC TARGETING; MESOPOROUS SILICA NANOPARTICLE; SUSTAINED RELEASE;

ALGINATES; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; NANOPARTICLES; SILICON DIOXIDE;

EID: 84892445384     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33007     Document Type: Article

References (41)

1. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY,. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008; 60 (11): 1278-1288.
2. Zhang CM, Li CX, Huang SS, Hou ZY, Cheng ZY, Yang PP, Peng C, Lin J,. Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials 2010; 31 (12): 3374-3383.
3. Jatzkewitz H,. An ein kolloidales blutplasmaersatzmittel (polyvinylpyrrolidon) gebundenes peptamin (glycyl- l -leucyl-mezcalin) als neuartige depotform fur biologisch aktive primare amine (mezcalin). Z Naturforsch 1955; 10: 27-31.
4. Chiou WL, Smith LD,. Solid dispersion approach to the formulation of organic liquid drugs using polyethylene glycol 6000 as a carrier. J Pharm Sci 1971; 60 (1): 125-127.
5. Molteni L,. Dextran and insulin conjugates as drug carriers. Methods Enzymol 1985; 112: 285-298.
6. Kawaguchi H,. Functional polymer microspheres. Progr Polym Sci 2000; 25 (8): 1171-1210.
7. Jones MC, Leroux JC,. Polymeric micelles-A new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999; 48 (2): 101-111.
8. Peppas NA, Keys KB, Torres-Lugo M, Lowman AM,. Poly(ethylene glycol)-containing hydrogels in drug delivery. J Controlled Release 1999; 62 (1-2): 81-87.
9. Kim JH, Kim YS, Park K, Kang E, Lee S, Nam HY, Kim K, Park JH, Chi DY, Park RW, Kim IS, Choi K, Chan Kwon I,. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials 2008; 29 (12): 1920-1930.
10. Yun YH, Goetz DJ, Yellen P, Chen WL,. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004; 25 (1): 147-157.
11. Nanjwade BK, Singh J, Parikh KA, Manvi FV,. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles. Int J Pharm 2010; 385 (1-2): 176-180.
12. Clark AH, Rossmurphy SB,. Structural and mechanical-properties of bio-polymer gels. Adv Polym Sci 1987; 83: 57-192.
13. Novikova LN, Mosahebi A, Wiberg M, Terenghi G, Kellerth JO, Novikov LN,. Alginate hydrogel and matrigel as potential cell carriers for neurotransplantation. J Biomed Mater Res Part A 2006; 77A (2): 242-252.
14. Tan WH, Takeuchi S,. Monodisperse alginate hydrogel microbeads for cell encapsulation. Adv Mater 2007; 19 (18): 2696-2701.
15. Knill CJ, Kennedy JF, Mistry J, Miraftab M, Smart G, Groocock MR, Williams HJ,. Alginate fibres modified with unhydrolysed and hydrolysed chitosans for wound dressings. Carbohydr Polym 2004; 55 (1): 65-76.
16. West TP, Preece JE,. Bulk alginate encapsulation of Hibiscus moscheutos nodal segments. Plant Cell Tiss Organ Cult 2009; 97 (3): 345-351.
17. Srivastava R, McShane MJ,. Application of self-assembled ultra-thin film coatings to stabilize macromolecule encapsulation in alginate microspheres. J Microencapsulation 2005; 22 (4): 397-411.
18. Motwani SK, Chopra S, Talegaonkar S, Kohl K, Ahmad FJ, Khar RK,. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008; 68 (3): 513-525.
19. Hu Y, Hu N,. pH-dependent behaviors of electroactive myoglobin loaded into layer-by-layer films assembled with alginate and hydroxyethyl cellulose ethoxylate. J Phys Chem B 2008; 112 (31): 9523-9531.
20. Chan ES, Lim TK, Ravindra P, Mansa RF, Islam A,. The effect of low air-to-liquid mass flow rate ratios on the size, size distribution and shape of calcium alginate particles produced using the atomization method. J Food Eng 2012; 108 (2): 297-303.
21. Yanagisawa T, Shimizu T, Kuroda K, Kato C,. The preparation of alkyltrimethylammonium-kanemite complexes and their conversion to microporous materials. Bull Chem Soc Jpn 1990; 63 (4): 988-992.
22. Beck JS, Vartuli JC, Roth WJ, Leonowicz ME, Kresge CT, Schmitt KD, Chu CTW, Olson DH, Sheppard EW, McCullen SB,. A new family of mesoporous molecular-sieves prepared with liquid-crystal templates. J Am Chem Soc 1992; 114 (27): 10834-10843.
23. Nakahira A, Nagata H, Onoki T, Yamasaki Y,. Evaluation of microstructures and properties of bulk mesoporous silica. Res Chem Intermed 2008; 34 (4): 347-352.
24. Hu Y, Zhi Z, Zhao Q, Wu C, Zhao P, Jiang H, Jiang T, Wang S,. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous Mesoporous Mater 2012; 147 (1): 94-101.
25. Grosso D, Balkenende AR, Albouy PA, Ayral A, Amenitsch H, Babonneau F,. Two-dimensional hexagonal mesoporous silica thin films prepared from black copolymers: Detailed characterization amd formation mechanism. Chem Mater 2001; 13 (5): 1848-1856.
26. Haufova P, Knejzlik Z, Jaroslav H, Zadrazil A, Stepanek F,. Reversible buckling and diffusion properties of silica-coated hydrogel particles. J Colloid Interface Sci 2011; 357 (1): 109-115.
27. Lim SY, Kim KO, Kim DM, Park CB,. Silica-coated alginate beads for in vitro protein synthesis via transcription/translation machinery encapsulation. J Biotechnol 2009; 143 (3): 183-189.
28. Xu SW, Jiang ZY, Lu Y, Wu H, Yuan WK,. Preparation and catalytic properties of novel alginate-silica-dehydrogenase hybrid biocomposite beads. Ind Eng Chem Res 2006; 45 (2): 511-517.
29. Coradin T, Livage J,. Mesoporous alginate/silica biocomposites for enzyme immobilisation. C R Chim 2003; 6 (1): 147-152.
30. Joshi A, Keerthiprasad R, Jayant RD, Srivastava R,. Nano-in-micro alginate based hybrid particles. Carbohydr Polym 2010; 81 (4): 790-798.
31. Chang RHY, Jang J, Wu KCW,. Cellulase immobilized mesoporous silica nanocatalysts for efficient cellulose-to-glucose conversion. Green Chem 2011; 13 (10): 2844-2850.
32. Herrero EP, Del Valle EMM, Galan MA,. Development of a new technology for the production of microcapsules based in atomization processes. Chem Eng J 2006; 117 (2): 137-142.
33. Rizk NK, Lefebvre AH,. The influence of liquid-film thickness on airblast atomization. J Eng Power Trans ASME 1980; 102 (3): 706-710.
34. Dombrowski N, Johns WR,. The aerodynamic instability and disintegration of viscous liquid sheets. Chem Eng Sci 1963; 18 (3): 203-214.
35. Shimoda A, Sawada S, Akiyoshi K,. Cell specific peptide-conjugated polysaccharide nanogels for protein delivery. Macromol Biosci 2011; 11 (7): 882-888.
36. Morgan AW, Roskov KE, Lin-Gibson S, Kaplan DL, Becker ML, Simon CG Jr,. Characterization and optimization of RGD-containing silk blends to support osteoblastic differentiation. Biomaterials 2008; 29 (16): 2556-2563.
37. Choi KY, Yoon HY, Kim JH, Bae SM, Park RW, Kang YM, Kim IS, Kwon IC, Choi K, Jeong SY, Kim K, Park JH,. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano 2011; 5 (11): 8591-8599.
38. Brandhonneur N, Chevanne F, Vie V, Frisch B, Primault R, Le Potier M-F, Le Corre P,. Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages. Eur J Pharm Sci 2009; 36 (4-5): 474-485.
39. Petros RA, DeSimone JM,. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discovery 2010; 9 (8): 615-627.
40. Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, Linden M,. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009; 3 (1): 197-206.
41. Yu KO, Grabinski CM, Schrand AM, Murdock RC, Wang W, Gu B, Schlager JJ, Hussain SM,. Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J Nanopart Res 2009; 11 (1): 15-24.